Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85%
³»   ¿ë

¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85%

ºÏÇÑÀÌÅ»ÁֹΠÆ÷Ä¿½º±×·ì ÀÎÅÍºä °á°ú ¹× 2019³â ¾à ¹Ù¸£°Ô ¾Ë±â <5>


Âü¿© ¿¬±¸¿ø Á¤½Â¿¬ ¼±ÀÓ¿¬±¸¿ø/Á¤µ¿¿í ºÎ¼±ÀÓ¿¬±¸¿ø
ÆíÁý ÀÓÀ翵 ½ÇÀå/ÀÌÁÖÇÏ ÁÖÀÓ¿¬±¸¿ø

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â ´ëÇѾà»çȸÀÇ '¾à¹Ù·Î¾²±â¿îµ¿º»ºÎ'°¡ ÁøÇàÇÑ ½ÄǰÀǾàǰ¾ÈÀüó ¹ßÁÖ ¿ë¿ª »ç¾÷ÀΠ¡®2020³â ¾à¹Ù¸£°Ô¾Ë±â ±³À°»ç¾÷¡®ÀÇ Æò°¡¸¦ ÁøÇàÇß´Ù. À̴ 2018, 2019³â¿¡ À̾à»çȸÀÇ ¿ë¿ªÀ¸·Î ¼¼¹øÂ°·Î ÁøÇàµÈ »ç¾÷(Æò°¡)ÀÌ´Ù. 2019³â Àå¾ÖÀΠ¹× Àå¾ÖÀΠ´ã´ç ±³»ç¸¦ ´ë»óÀ¸·Î ÁøÇàÇß´ø Ãë¾à°èÃþ ½Ã¹ü±³À°¿¡ À̾î 2020³â¿¡´Â ºÏÇÑÀÌÅ»ÁÖ¹ÎÀ» Ãë¾à°èÃþ ½Ã¹ü±³À° ´ë»óÀ¸·Î ¼±Á¤ÇØ À̵鿡°Ô ÀǾàǰ »ç¿ë ±³À°À» ½ÃÇàÇϱ⠾ռ­ Æ÷Ä¿½º±×·ìÀÎÅͺ並 ÁøÇàÇß´Ù.

2020³â 9¿ù ±âÁØ, Çѱ¹¿¡ ÀÔ±¹ÇÑ ºÏÇÑÀÌÅ»ÁÖ¹ÎÀº ÃÑ 3¸¸ 3718¸íÀÌ´Ù. 2000³â´ë ÀÌÈÄ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇØ 2003~2011³â¿¡´Â ¿¬°£ ÀÔ±¹ ÀοøÀÌ 2000¸í~3000¸í ¼öÁØ¿¡ À̸£·¶À¸³ª, 2012³â ÀÌÈÄ ÀÔ±¹ ÀοøÀÌ Á¡Â÷ ÁÙ¾îµé¾î ¿¬°£ Æò±Õ 1300¸í´ë·Î °¨¼ÒÇß°í, 2019³âµµ¿¡´Â 1047¸í ÀÔ±¹Çß´Ù. ÃÖ±Ù Äڷγª19ÀÇ ¿µÇâÀ¸·Î ÀÎÇÑ Å»ºÏ À̵¿ °æ·Î ±¹°¡ÀÇ ±¹°æ Æó¼â µîÀÇ ¿øÀÎÀ¸·Î ±× ¼ö´Â Å©°Ô °¨¼ÒÇϰí Àִ Ãß¼¼ÀÌ´Ù. ÇÏÁö¸¸ Äڷγª19 ÆÒµ¥¹ÍÀÌ ³¡³­ ÀÌÈÄ ¶Ç ±× ¼ö´Â Å©°Ô Áõ°¡ÇÒ ¼ö ÀÖ´Ù. Çѱ¹¿¡ Á¤ÂøÇÑ ÀÌÈÄ ºÏÇÑÀÌÅ»ÁÖ¹ÎÀÇ ÀÇ·á ¼­ºñ½º À̿령נÀǾàǰÀÇ º¹¿ë ÇàŰ¡ ±âÁ¸ÀÇ ±¹¹Î°ú´Â ´Ù¸£´Ù´Â Á¡ÀÌ º¸°íµÇ°í ÀÖ´Ù. ÀÌ¿¡ º» ¿¬±¸¼Ò´Â À̵éÀÇ °ú°Å ¹× ÇöÀçÀÇ ÀǾàǰ¿¡ ´ëÇÑ ÀνĠ¹× »ç¿ë ÇöȲÀ» ÆÄ¾ÇÇϰí À̸¦ Åä´ë·Î À̵éÀÇ Çʿ信 ºÎÇÕÇÑ ¸ÂÃãÇü ÀǾàǰ »ç¿ë ±³À°À» Á¦°øÇϴ °ÍÀ» ¸ñÇ¥·Î Æ÷Ä¿½º±×·ìÀÎÅͺ並 ÁøÇàÇß´Ù. 

ÀÌ¿¡ ¸ÕÀú ºÏÇÑÀÌÅ»ÁֹΠ´ë»ó Æ÷Ä¿½º±×·ì ÀÎÅͺ䠰á°ú¿Í ÇÔ²² À̵éÀ» À§ÇÑ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°¿¡ Æ÷ÇԵǾî¾ß ÇÒ °ÍÀ¸·Î Á¦¾ÈÇß´ø ³»¿ëÀ» ¼Ò°³ÇϰíÀÚ ÇÑ´Ù. ¸¶Áö¸·À¸·Î À̵éÀ» ´ë»óÀ¸·Î ÁøÇàÇß´ø ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°ÀÇ Æò°¡ °á°ú¸¦ ÅëÇØ ºÏÇÑÀÌÅ»ÁֹΠ´ë»ó ±³À° ¼öÇàÀÇ Àǹ̿͠³ª¾Æ°¥ ¹æÇâ¿¡ ´ëÇØ °íÂûÇØ º¸°íÀÚ ÇÑ´Ù.


<Áö³­È£¿¡ À̾>
³ª. ºÏÇÑÀÌÅ»ÁֹΠ´ë»ó ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° Æò°¡
(4) ÇâÈÄ ±³À° Âü¿© ÀÇÇâ
ÃßÈÄ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°¿¡ Âü¿©Çϰڴٰí ÀÀ´äÇÑ ºñÀ²Àº ¾à 98% ·Î ¾ÆÁÖ ³ô°Ô ³ªÅ¸³µ´Ù. À̴ À̵éÀÌ ÀǾàǰ »ç¿ë ±³À°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô´Ù´Â °ÍÀ» ÀÔÁõÇϴ °ÍÀÌ´Ù.


(5) ¾à±¹¿¡¼­ ¾à ±¸ÀÔ ½Ã Áß¿äÇÑ ¿äÀÎ
ºÏÇÑÀÌÅ»ÁÖ¹ÎÀÇ °æ¿ì ¾à±¹¿¡¼­ ¾à ±¸ÀÔ Áß¿äÇÑ ¿äÀÎÀ¸·Î ¾à»ç¿ÍÀÇ »ó´ãÀÌ 85%, ´ÙÀ½À¸·Î TV ±¤°í°¡ 13%·Î ÀÀ´äÇß´Ù. À̰ÍÀ¸·Î ºÏÇÑÀÌÅ» ÁÖ¹ÎÀº ¾à»çÀÇ ±ÇÀ¯³ª ÀǰßÀ» Áß¿äÇϰԠ»ý°¢Çϰí Àִٴ °æÇâÀ» ¾Ë ¼öÀÖ´Ù.


³ª°¡¸ç
ÀǾàǰÀÇ ÀνĠ¹× »ç¿ë °æÇè µîÀ» µÑ·¯½Ñ ³²ºÏÇÑÀÇ º¸°ÇÀǷᠽýºÅÛ ¹× È¯°æÀÇ Â÷À̴ »ó´çÈ÷ Å©´Ù. ºÏÇÑÀÌÅ»ÁÖ¹ÎÀ» ´ë»óÀ¸·Î ÁøÇàÇÑ Æ÷Ä¿½º±×·ìÀÎÅͺ䠰á°ú, À̵éÀÇ Çѱ¹ Á¤Âø ÀÌÀüÀÇ ÀǾàǰ¿¡ ´ëÇÑ Àνİú »ç¿ë °æÇèÀº º¸ÅëÀÇ Çѱ¹ »ç¶÷°ú ¸î °¡Áö ´Ù¸¥ Æ¯Â¡µéÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù.

À̵éÀº ¸öÀÌ ¾ÆÇà¶§ ÁַΠÀÚ°¡Áø´ÜÇØ ¾à±¹À̳ª º´¿øÀÌ ¾Æ´Ñ À帶´çÀ̳ª ÁöÀÎÀ» ÅëÇØ ¾àÀ» ±¸ÀÔÇØ º¹¿ëÇß°í, Á÷Á¢ ¾ÆÆíÀ» Àç¹èÇÏ¿© ¸Ô±âµµ ÇÏ¿´´Ù. ¶ÇÇÑ Á¤ÅëÆí°ú °°Àº ¸¶¾à ¼ººÐÀÇ ¾àÀ» ¿À·£±â°£ º¹¿ëÇßÀ¸¸ç, ÀǾàǰÀÇ »ç¿ë±â°£¿¡ ´ëÇÑ ÀνÄÀÌ ºÎÁ·ÇÑ °Í°ú °°Àº Æ¯Â¡µéÀ» º¸¿´´Ù.

Çѱ¹¿¡ ÀÔ±¹ÇÑ ÀÌÈÄ¿¡µµ ºÏÇÑÀ̳ª °æÀ¯±¹¿¡¼­ »ç¿ëÇÏ¿´´ø ÀǾàǰ(¿¹: Á¤ÅëÆí)À» Áö¼ÓÀûÀ¸·Î ±¸ÀÔÇØ º¹¿ëÇϰí ÀÖ¾ú´Ù. ¶ÇÇÑ ÀÇ·áÀü¹®°¡ÀÇ ÆÇ´Üº¸´Ù´Â ¿©ÀüÈ÷ ÀÚ½ÅÀÇ ÆÇ´Ü¿¡ Å©°Ô ÀÇÁ¸ÇØ ÀǾàǰÀ» º¹¿ëÇϰí ÀÖ¾ú´Ù.

ƯÈ÷ ³²ºÏÇÑ ¿ë¾î ¹× ¹ßÀ½ÀÇ Â÷À̷ΠÀÎÇÑ ÀÇ»ç¼ÒÅëÀÇ ¹®Á¦¿Í ÇÔ²² ÀǾàǰ Ç¥½Ã Á¤º¸ ÀÌÇØÀÇ ¾î·Á¿ò µîÀÇ ¹®Á¦¸¦ °æÇèÇϰí ÀÖ¾ú´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ °á°ú¸¦ Åä´ë·Î ºÏÇÑÀÌÅ»ÁÖ¹ÎÀ» À§ÇÑ ¸ÂÃãÇü ÀǾàǰ ¾ÈÀü »ç¿ë ±³À°ÀÌ ÇÊ¿äÇÏ´Ù.

ºÏÇÑÀÌÅ»ÁֹΠ½Ã¹ü±³À°»ç¾÷¿¡ ´ëÇÑ Æò°¡ °á°ú·Î¼­ ½ÇÁ¦ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°¿¡ Âü¿©ÇÑ ºÏÇÑÀÌÅ»ÁÖ¹ÎÀÇ ±³À° ¸¸Á·µµ´Â ¸Å¿ì ³ô°Ô ³ªÅ¸³µ´Ù. ¶ÇÇÑ ÇâÈÄ À̿͠°°Àº ±³À°¿¡ Âü¿©ÇϰíÀÚ Çϴ ÀÇÁöµµ ³ô¾Ò´Ù. À̴ À̵鿡°Ô ÀǾàǰ »ç¿ë°ú °ü·ÃÇÑ ±³À° ¼ö¿ä°¡ ³ô´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ÇâÈÄ À̵éÀ» À§ÇÑ ±³À°ÀÌ ´Ù¾çÇÑ ÇüÅ·ΠÇϳª¿ø°ú Çϳª¼¾ÅÍ, Àϼ± Áö¿ª¾à±¹¿¡¼­µµ ÁøÇàµÉ Çʿ䰡 À־¸ÀδÙ.

¾à 3¸¸¿©¸íÀÇ ºÏÇÑÀÌÅ»ÁÖ¹ÎÀÌ Çѱ¹¿¡ Á¤ÂøÇÏ¿© »ì°í ÀÖ´Ù. À̵éÀÇ ¿Ã¹Ù¸¥ ÀǾàǰ »ç¿ëÀ» À§Ç졒ʱ̱ØÀûÀ¸·Î À̵éÀÌ Çѱ¹¿¡¼­ »ý¸í°ú °Ç°­À» Àß Áöų ¼ö ÀÖµµ·Ï À̵éÀǠƯ¼ºÀ» ¹Ý¿µÇÑ ÀǾàǰ »ç¿ë ±³À°°ú ´Ù¾çÇÑ ¹æ¾ÈµéÀÌ Áö¼ÓÀûÀ¸·Î ³íÀǵǰí Ã¼°èÀûÀ¸·Î º¯È­ÇÏ°í ¹ßÀüÇØ ³ª¾Æ°¥ ¼ö Àֱ⸦ ±â´ëÇϴ ¹ÙÀÌ´Ù.


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=722

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 898
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 777
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 755
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 762
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 249
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 519
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 458
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 505
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 446
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 389
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 463
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 451
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 484
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 431
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 439

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»